Cargando…
Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)
Chitosan oligosaccharides (COS) display various biological activities. In this study, we aimed to explore the preventive effects of COS on glucolipid metabolism disorder using palmitic acid (PA)-induced HepG2 cells and high-fat diet (HFD)-fed C57BL/6J mice as experimental models in vitro and in vivo...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265870/ https://www.ncbi.nlm.nih.gov/pubmed/30463189 http://dx.doi.org/10.3390/md16110455 |
_version_ | 1783375712562970624 |
---|---|
author | Bai, Yibo Zheng, Junping Yuan, Xubing Jiao, Siming Feng, Cui Du, Yuguang Liu, Hongtao Zheng, Lanyan |
author_facet | Bai, Yibo Zheng, Junping Yuan, Xubing Jiao, Siming Feng, Cui Du, Yuguang Liu, Hongtao Zheng, Lanyan |
author_sort | Bai, Yibo |
collection | PubMed |
description | Chitosan oligosaccharides (COS) display various biological activities. In this study, we aimed to explore the preventive effects of COS on glucolipid metabolism disorder using palmitic acid (PA)-induced HepG2 cells and high-fat diet (HFD)-fed C57BL/6J mice as experimental models in vitro and in vivo, respectively. The results showed that COS pretreatment for 12 h significantly ameliorated lipid accumulation in HepG2 cells exposed to PA for 24 h, accompanied by a reversing of the upregulated mRNA expression of proinflammatory cytokines (IL-6, MCP-1, TNF-α) and glucolipid metabolism-related regulators (SCD-1, ACC1, PCK1-α). In addition, COS treatment alleviated glucolipid metabolism disorder in mice fed with HFD for five months, including reduction in body weight and fasting glucose, restoration of intraperitoneal glucose tolerance, and suppression of overexpression of proinflammatory cytokines and glucolipid metabolism-related regulators. Furthermore, our study found that COS pretreatment significantly reversed the downregulation of PPARγ at transcriptional and translational levels in both PA-induced HepG2 cells and liver tissues of HFD-fed mice. In summary, the study suggests that COS can improve glucolipid metabolism disorder by suppressing inflammation and upregulating PPARγ expression. This indicates a novel application of COS in preventing and treating glucolipid metabolism-related diseases. |
format | Online Article Text |
id | pubmed-6265870 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62658702018-12-06 Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Bai, Yibo Zheng, Junping Yuan, Xubing Jiao, Siming Feng, Cui Du, Yuguang Liu, Hongtao Zheng, Lanyan Mar Drugs Article Chitosan oligosaccharides (COS) display various biological activities. In this study, we aimed to explore the preventive effects of COS on glucolipid metabolism disorder using palmitic acid (PA)-induced HepG2 cells and high-fat diet (HFD)-fed C57BL/6J mice as experimental models in vitro and in vivo, respectively. The results showed that COS pretreatment for 12 h significantly ameliorated lipid accumulation in HepG2 cells exposed to PA for 24 h, accompanied by a reversing of the upregulated mRNA expression of proinflammatory cytokines (IL-6, MCP-1, TNF-α) and glucolipid metabolism-related regulators (SCD-1, ACC1, PCK1-α). In addition, COS treatment alleviated glucolipid metabolism disorder in mice fed with HFD for five months, including reduction in body weight and fasting glucose, restoration of intraperitoneal glucose tolerance, and suppression of overexpression of proinflammatory cytokines and glucolipid metabolism-related regulators. Furthermore, our study found that COS pretreatment significantly reversed the downregulation of PPARγ at transcriptional and translational levels in both PA-induced HepG2 cells and liver tissues of HFD-fed mice. In summary, the study suggests that COS can improve glucolipid metabolism disorder by suppressing inflammation and upregulating PPARγ expression. This indicates a novel application of COS in preventing and treating glucolipid metabolism-related diseases. MDPI 2018-11-19 /pmc/articles/PMC6265870/ /pubmed/30463189 http://dx.doi.org/10.3390/md16110455 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bai, Yibo Zheng, Junping Yuan, Xubing Jiao, Siming Feng, Cui Du, Yuguang Liu, Hongtao Zheng, Lanyan Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) |
title | Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) |
title_full | Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) |
title_fullStr | Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) |
title_full_unstemmed | Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) |
title_short | Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) |
title_sort | chitosan oligosaccharides improve glucolipid metabolism disorder in liver by suppression of obesity-related inflammation and restoration of peroxisome proliferator-activated receptor gamma (pparγ) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265870/ https://www.ncbi.nlm.nih.gov/pubmed/30463189 http://dx.doi.org/10.3390/md16110455 |
work_keys_str_mv | AT baiyibo chitosanoligosaccharidesimproveglucolipidmetabolismdisorderinliverbysuppressionofobesityrelatedinflammationandrestorationofperoxisomeproliferatoractivatedreceptorgammapparg AT zhengjunping chitosanoligosaccharidesimproveglucolipidmetabolismdisorderinliverbysuppressionofobesityrelatedinflammationandrestorationofperoxisomeproliferatoractivatedreceptorgammapparg AT yuanxubing chitosanoligosaccharidesimproveglucolipidmetabolismdisorderinliverbysuppressionofobesityrelatedinflammationandrestorationofperoxisomeproliferatoractivatedreceptorgammapparg AT jiaosiming chitosanoligosaccharidesimproveglucolipidmetabolismdisorderinliverbysuppressionofobesityrelatedinflammationandrestorationofperoxisomeproliferatoractivatedreceptorgammapparg AT fengcui chitosanoligosaccharidesimproveglucolipidmetabolismdisorderinliverbysuppressionofobesityrelatedinflammationandrestorationofperoxisomeproliferatoractivatedreceptorgammapparg AT duyuguang chitosanoligosaccharidesimproveglucolipidmetabolismdisorderinliverbysuppressionofobesityrelatedinflammationandrestorationofperoxisomeproliferatoractivatedreceptorgammapparg AT liuhongtao chitosanoligosaccharidesimproveglucolipidmetabolismdisorderinliverbysuppressionofobesityrelatedinflammationandrestorationofperoxisomeproliferatoractivatedreceptorgammapparg AT zhenglanyan chitosanoligosaccharidesimproveglucolipidmetabolismdisorderinliverbysuppressionofobesityrelatedinflammationandrestorationofperoxisomeproliferatoractivatedreceptorgammapparg |